Topical Drug Bioavailability, Bioequivalence, and Penetration
Professor Maibach is a leading authority in the fields of dermatotoxicology and dermatopharmacology, in which he has conducted research and written extensively. John Jenner is a principal scientist at The Defence Science and Technology Laboratory in the UK. He has a degree in pharmacology from the U...
| Other Authors: | , , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
New York, NY
Springer New York
2014, 2014
|
| Edition: | 2nd ed. 2014 |
| Subjects: | |
| Online Access: | |
| Collection: | Springer eBooks 2005- - Collection details see MPG.ReNa |
Table of Contents:
- 1 Percutaneous Absorption
- 2 Animal Models for Percutaneous Absorption
- 3 Mitigating Dermal Exposure to Agrochemicals
- 4 Importance of In Vitro Drug Release
- 5 Diffusion Cell Design
- 6 In Vitro Product Quality Tests and Product Performance Tests for Topical and Transdermal Drug Products
- 7 Safety and efficacy testing of topical products; Practical considerations
- 8 Challenges in Evaluating Bioequivalence of Topical Dermatological Drug Products
- 9 Methods for the Assessment of Bioequivalence of Topical Dosage Forms: Correlations, Optimization Strategies and Innovative Approaches
- 10 Application of Microdialysis in Assessing Cutaneous Bioavailability
- 11 Follicular Drug Penetration
- 12 Development of Pilosebaceous Unit-Targeted Drug Products
- 13 Deep Percutaneous Penetration into Muscles and Joints: Update
- 14 Efficacy & Toxicity of Microneedle based devices
- 15 Mathematical Models for Topical and Transdermal Drug Products
- 16 Transdermal Patches: An Industrial Perspective on the Relevance of in vitro Skin Permeation Studies and Approaches on Design of Manufacturing Processes
- 17 Transdermal Drug Delivery Systems. Regulatory Considerations: NDA and ANDA Requirements
- 18 Transdermal Estradiol and Testosterone Transfer in Man: Existence, Models, and Strategies for Prevention
- 19 Effects of occlusion on dermal drug delivery: implications for bioequivalence measurement
- 20 Challenges with Clinical Endpoints – Bioequivalence
- 21 Clinical Considerations of Bioequivalence For Topical Dermatologic Drugs
- 22 OECD Test Guideline 428 – A method for in vitro percutaneous absorption measurement?
- 23 Bioequivalence, Quality, and Novel Assessment Technologies for Topical Products: Current Challenges and Future Prospects